Iran plans to buy 12 Superjet-100 Russian aircraft in near future — ministerBusiness & Economy February 22, 8:24
Kiev proposes removing Russia’s veto power in UN Security CouncilWorld February 22, 2:31
Trump says saddened to learn of death of Russia’s Permanent Representative to UN ChurkinWorld February 22, 1:56
Lavrov says Russia-Belarus relations developing in working modeRussian Politics & Diplomacy February 21, 21:48
Condolence book in memory of Churkin opened at Russia’s Permanent Mission to UNWorld February 21, 20:53
Ukrainian billionaire Dmitry Firtash detained in Vienna at Spain’s requestWorld February 21, 20:40
UN secretary-general offers Lavrov condolences on Churkin’s deathWorld February 21, 19:53
OPEC does not see problems regarding growth of Russian oil exportBusiness & Economy February 21, 19:46
Kremlin to bake 100,000 pancakes for MaslenitsaSociety & Culture February 21, 19:23
LONDON, June 14. /TASS/. Russian tennis star Maria Sharapova said she would file an appeal with the Court of Arbitration for Sports (CAS) against her two-year suspension, imposed last week by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations, Britain’s web portal Sky News reported on Tuesday.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.